Exane Derivatives’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,246
| Closed | -$54.1K | – | 1016 |
|
|
2021
Q4 | $54.1K | Buy |
3,246
+999
| +44% | +$16.7K | 0.01% | 483 |
|
|
2021
Q3 | $105K | Sell |
2,247
-321
| -13% | -$15K | 0.03% | 505 |
|
|
2021
Q2 | $161K | Buy |
2,568
+930
| +57% | +$58.3K | 0.04% | 442 |
|
|
2021
Q1 | $101K | Buy |
1,638
+1,143
| +231% | +$70.4K | 0.03% | 411 |
|
|
2020
Q4 | $35.2K | Buy |
+495
| New | +$35.2K | 0.01% | 472 |
|